The Global Helicobacter Pylori Diagnostic Market Size is valued at 559.89 million in 2023 and is predicted to reach 911.50 million by the year 2031 at a 6.31% CAGR during the forecast period for 2024-2031.
Helicobacter pylori (H. pylori), an aerobic, gram-negative bacterium, is frequently found in the stomach. It is vital to the preservation of the stomach environment. The spiral-shaped bacteria that cause H. infection with pylori penetrate the esophagus, small intestine, and stomach lining, increasing the risk of gastric cancer, peptic ulcers, and chronic gastritis.
One of the most significant factors that will contribute to the growth of the helicobacter pylori diagnostic market is the rising number of patients with gastric ulcers. Other important factors include the rising prevalence of geriatrics worldwide, the rising demand for point-of-care testing devices, the growing adoption of non-invasive testing, and the simple accessibility of diagnostic tests.
On the other hand, growing technological development, increased innovations, and increased product approvals will all contribute to expanding the helicobacter pylori diagnostic market during the period covered by the projections above. In emerging nations, there are expected to be market restrictions on developing the helicobacter pylori diagnostic market due to a lack of experienced specialists and knowledge about the advantages of testing.
The Helicobacter pylori diagnostic market is segmented by technology and end user. The technology segment includes Immunoassays, POC, and Molecular Diagnostics. By the end user, the market is segmented into Hospitals, Diagnostics Laboratories, and Clinics.
The immunoassay segment had the most significant market share and is expected to continue to dominate the market over the coming years. For the detection of antibodies, a number of cutting-edge technologies are used, such as enzyme immunoassays. Serology, fast urease tests, and urea breath tests are a few of the indirect tests. Although molecular diagnostics represented the second-largest market share, POC tests still accounted for some of the most frequently employed methods.
Due to the simplicity of disease presentation, the accessibility of doctors, and the increased occurrence of diseases such as duodenal ulcers, stomach cancer, gastritis, gastric ulcers, and infections of the small intestine, hospitals held the most significant market share.
Throughout the projection period, North America is expected to dominate the global market for helicobacter pylori diagnostics. Infectious disease instances, awareness of contagious diseases, and introduction of new products are all contributing causes to the growth. For instance, Biomerica Inc. announced in June 2021 that it had inked a five-year exclusive distribution agreement with a Canadian partner to distribute and market Biomerica's innovative and exclusive Helicobacter pylori test, known as hp+detect. Helicobacter pylori infection, the most common cause of duodenal and gastric ulcers and a risk factor for stomach cancer, have been targeted by developing the hp+detect product. Therefore, such occurrences are projected to fuel market growth in the North American area.
|
Report Attribute |
Specifications |
|
Market size value in 2023 |
USD 559.89 Mn |
|
Revenue forecast in 2031 |
USD 911.50 Mn |
|
Growth rate CAGR |
CAGR of 6.31% from 2024 to 2031 |
|
Quantitative units |
Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments covered |
Technology And End User |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
|
Competitive Landscape |
Thermo Fisher Scientific, Biohit, Quest Diagnostics, Meridian Bioscience, Bio-Rad Laboratories, Alpha Laboratories, F. Hoffmann-La Roche, Coris BioConcept, Certest Biotec, and Epitope Diagnostics. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Helicobacter Pylori Diagnostics Market Snapshot
Chapter 4. Global Helicobacter Pylori Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Technology Estimates & Trend Analysis
5.1. by Technology & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Technology:
5.2.1. Immunoassays
5.2.2. POC
5.2.3. Molecular Diagnostics
Chapter 6. Market Segmentation 2: by End-users Estimates & Trend Analysis
6.1. by End-users & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-users:
6.2.1. Hospitals
6.2.2. Diagnostics Laboratories
6.2.3. Clinics
Chapter 7. Helicobacter Pylori Diagnostics Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2023-2031
7.1.2. North America Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.1.3. North America Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.2. Europe
7.2.1. Europe Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2023-2031
7.2.2. Europe Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.2.3. Europe Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2023-2031
7.3.2. Asia Pacific Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.3.3. Asia Pacific Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.4. Latin America
7.4.1. Latin America Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2023-2031
7.4.2. Latin America Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.4.3. Latin America Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2023-2031
7.5.2. Middle East & Africa Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by End-users, 2023-2031
7.5.3. Middle East & Africa Helicobacter Pylori Diagnostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Abbott
8.2.2. Agilent Technologies, Inc.
8.2.3. Alpha Laboratories
8.2.4. Avanos Medical Devices.
8.2.5. Biohit Oyj
8.2.6. Bio-Rad Laboratories
8.2.7. Cardinal Health, Inc.
8.2.8. Certest Biotec
8.2.9. CorisBioconcept SPRL
8.2.10. EKF Diagnostics
8.2.11. Epitope Diagnostics
8.2.12. Exalenz Bioscience Ltd.
8.2.13. F. Hoffmann-La Roche Ltd
8.2.14. Gulf Coast Scientific
8.2.15. Halyard Health, Inc.
8.2.16. Helena Laboratories Corporation
8.2.17. HORIBA Europe GmbH
8.2.18. Medline Industries, Inc.
8.2.19. Meridian Bioscience, Inc.
8.2.20. QIAGEN
8.2.21. Quest Diagnostics
8.2.22. Quidel Corporation.
8.2.23. Sekisui Diagnostics
8.2.24. Takara Bio Inc.
8.2.25. Thermo Fisher Scientific, Inc.
8.2.26. Other Prominent Players
Helicobacter Pylori Diagnostic Market By Technology-
Helicobacter Pylori Diagnostic Market By End-User-
Helicobacter Pylori Diagnostic Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
